Ishikawa

Target ID: CHEMBL614649

Organism: Homo sapiens

Type: CELL-LINE

View on ChEMBL

Molecules

Name SMILES Bioactivity Structure
GENISTEIN O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12 IC50: 1000.0 nM
ERLOTINIB C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1 IC50: 1450.0 nM
2-METHOXYESTRADIOL COc1cc2c(cc1O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12 GI50: 700.0 nM
SUNITINIB CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C IC50: 80.0 nM
DAIDZEIN O=c1c(-c2ccc(O)cc2)coc2cc(O)ccc12 Suppression: 22.0 %
FULVESTRANT C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCC[S+]([O-])CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O IC50: 0.49 nM
CRIZOTINIB C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl IC50: 8.0 nM
RALOXIFENE HYDROCHLORIDE Cl.O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12 IC50: 0.4 nM
ESTRADIOL C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O IC50: 1.5 nM
IMATINIB Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1 IC50: 40.0 nM
GEFITINIB COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1 IC50: 515.0 nM
TOZASERTIB Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1 Ki: 0.6 nM
TAMOXIFEN CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1 IC50: 6750.0 nM
SORAFENIB CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1 IC50: 12.0 nM
ESTRONE C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O EC50: 1135.0 nM
RALOXIFENE O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12 IC50: 1.8 nM
SARACATINIB CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1 IC50: 2.7 nM

Top Fragments

SMILES Avg pKi Count Structure
[3*]O[3*] 7.47 279
[5*]N[5*] 7.48 273
[4*]CC[4*] 7.42 201
[16*]c1ccc([16*])cc1 8.01 201
[1*]C([6*])=O 7.91 156